International Clinical Trial: Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212582) titled 'Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)' on Oct. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Mahidol University

Condition: Critical Illness Septic Shock

Intervention: Drug: Human Albumin 20% Solution

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: December 1, 2025

Target Sample Size: 304

Countries of Recruitment: Thailand

To know more, visit https://clinicaltrials.gov/study/NCT...